Aldeyra The
- ALDX
- NASDAQ
- Biotechnology
- Dry Eye Treatment
- Allergy/Immune-Mediated Diseases
$0.67
Today −5.00%Quote Oct 19, 2026, 08:00 PM UTC
−51.10%over the last month
Max drawdown −52.3%From 1-month high −52.3%3 months −62.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Aldeyra The
Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
6
Founded
2004
Market value
$40.1M
Quote Oct 19
Floor
$0.59
11.8% below price
Resistance
$0.76
14.8% above price
Price vs analyst targets
19 analysts
Lowest target
$7.00Highest target
$12.00
$7.00Highest target
$12.00
- Price $0.67
- Average target $9.67
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 1354% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ALDXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free